Drug factory · FDA FEI 3009883135
Daicel Chiral Technologies (India) Private Limited
Survey No.542/2, IKP Knowledge Park Koltur Village, Shamirpet Mandal, Medchal Malkajgiri District, , Hyderabad, India
Problems found, fixed voluntarily at FDA's last inspection, Feb 14, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2016: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Belumosudil | Tests it | Kadmon Pharmaceuticals, LLC | 79802-200 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 14, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 3, 2023 | Problems found, fixed voluntarily | Bioresearch Monitoring | — |
| Mar 26, 2019 | No problems found | Bioresearch Monitoring | — |
| Feb 10, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis.